Fighting Anxiety with Importin-based Therapeutics

Project Information

FAITh

Grant agreement ID: 767058

DOI

10.3030/767058

Project closed

EC signature date 2 October 2017

Start date 1 November 2017

End date 30 April 2019

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 150 000,00

EU contribution

€ 150 000,00

Coordinated by

WEIZMANN INSTITUTE OF SCIENCE
Israel

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Importin α5 Regulates Anxiety through MeCP2 and Sphingosine Kinase 1

Author(s): Nicolas Panayotis, Anton Sheinin, Shachar Y. Dagan, Michael M. Tsoory, Franziska Rother, Mayur Vadhvani, Anna Meshcheriakova, Sandip Koley, Letizia Marvaldi, Didi-Andreas Song, Eitan Reuveny, Britta J. Eickholt, Enno Hartmann, Michael Bader, Izhak Michaelevski, Mike Fainzilber
Published in: Cell Reports, Issue 25/11, 2018, Page(s) 3169-3179.e7, ISSN 2211-1247
Publisher: Cell Press
DOI: 10.1016/j.celrep.2018.11.066

Intellectual Property Rights

Patent (1)

METHODS OF TREATING PSYCHIATRIC STRESS DISORDERS

Application/Publication number: WO 2018/207178
Date: 2018-05-07
Applicant(s): WEIZMANN INSTITUTE OF SCIENCE